Clinical Evidence Overview
Clinical evidence by class
| Class | Requirement |
|---|---|
| Class I | Generally not required for Notificação |
| Class II | Literature-based summary for Cadastro |
| Class III | Clinical evaluation report |
| Class IV | Comprehensive clinical evaluation; may require Brazil-specific clinical data |
Routes to clinical evidence
- Systematic literature review — structured search and critical appraisal of published data
- Substantial equivalence — demonstrating equivalence to a device with documented clinical data
- Clinical investigation in Brazil — under RDC 10/2015 for novel high-risk devices
Verify all information against official ANVISA sources before making regulatory decisions.
Class I devices registered via Notificação are generally exempt from pre-market clinical evidence requirements. However, any claims regarding therapeutic efficacy, diagnostic accuracy, or clinical benefit must be supported by published literature or technical justification; purely descriptive claims (e.g., 'sterile surgical gloves') do not require supporting evidence. Class I devices registered via Cadastro or higher pathways should include appropriate clinical justification.
Class I devices registered via Notificação are generally exempt from clinical evidence requirements, though safety-related claims may require supporting data. Class I devices registered via Cadastro or higher pathways should include appropriate clinical justification.